Patients with rheumatoid arthritis in clinical care

被引:58
|
作者
Smolen, JS
Aletaha, D
机构
[1] Univ Vienna, Vienna Gen Hosp Vienna, Dept Internal Med 3, Div Rheumatol, A-1090 Vienna, Austria
[2] Lainz Hosp, Dept Med 2, Vienna, Austria
关键词
D O I
10.1136/ard.2003.012575
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Taken together, our current clinical armamentarium to follow the course of RA offers several disease activity measures. Evaluation of radiographic destruction, but also of anatomical changes such as malalignment,77 can serve as outcome measure, because these changes best reflect the damage related to the pathological process in and around the joints; whether radiological changes can be reversible, is still a matter of debate. 78 Assessment of function reflects the combination of disease activity and damage. Questionnaires or other instruments which only determine functional improvement due to irreversible damage are not (yet) available. However, their development could lead to interesting, new clinical insights. Likewise, basic science has not yet provided us with tests that reflect the destructive process reliably. Measuring disease activity by surrogate measures such as the acute phase proteins does not reflect destruction at a single point in time. In conclusion, assessment of disease activity, damage, and functional capacity are equally important also in clinical practice; RA, if insufficiently controlled, may be a highly destructive disease. Achieving low disease activity, ideally a remission-like state, is pivotal to improving prognosis. 79 Current treatments and early institution of DMARDs allow this aim to be accomplished in many patients. However, decisions to switch (or to maintain) treatment require recording of the patients' clinical status, and in many healthcare systems the use of costly treatments, as increasingly employed, requires justification which, again, can only come from recorded data. 18 Rather than guessing disease activity and quality of life, providing evidence will validate decisions and improve quality of care. A combination of a more physician centred activity score, such as the SDAI or similar, with a patient centred functional measure, such as the HAQ or similar, in conjunction with an occasional evaluation of the radiographic situation, will give all necessary information for the longitudinal observation of patients' disease state in clinical practice. The tools are available and so relatively easy to use.
引用
收藏
页码:221 / 225
页数:5
相关论文
共 50 条
  • [21] Clinical profile and treatment outcomes of patients with rheumatoid arthritis at a tertiary care hospital of Pakistan
    Khaliq, Taqdees
    Khan, Asfandyar
    Malik, Iftikhar Ahmed
    JOURNAL OF THE PAKISTAN MEDICAL ASSOCIATION, 2020, 70 (07) : 1143 - 1148
  • [22] CLINICAL VASCULITIS IN RHEUMATOID-ARTHRITIS PATIENTS
    INAGAKI, K
    ZEITSCHRIFT FUR RHEUMATOLOGIE, 1980, 39 : 60 - 63
  • [23] Achieving Clinical Remission for Patients With Rheumatoid Arthritis
    Aletaha, Daniel
    Smolen, Josef S.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2019, 321 (05): : 457 - 458
  • [24] Quantitative assessment of rheumatoid arthritis in standard clinical care: turning clinical care into clinical science
    Sokka, Tbulikki
    BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY, 2007, 21 (04): : 653 - 661
  • [25] The evolution of biomarkers in rheumatoid arthritis: From clinical research to clinical care
    van den Broek, Theodorus
    Tesser, John R. P.
    Albani, Salvatore
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2008, 8 (11) : 1773 - +
  • [26] The clinical utility of accelerometry in patients with rheumatoid arthritis
    Prioreschi, Alessandra
    Hodkinson, Bridget
    Avidon, Ingrid
    Tikly, Mohammed
    McVeigh, Joanne A.
    RHEUMATOLOGY, 2013, 52 (09) : 1721 - 1727
  • [27] Quantitative measures for assessing rheumatoid arthritis in clinical trials and clinical care
    Pincus, T
    Sokka, T
    BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY, 2003, 17 (05): : 753 - 781
  • [28] IMPACT OF SEVERITY INDEX FOR RHEUMATOID ARTHRITIS ON HEALTH CARE COSTS AND UTILIZATIONS IN PATIENTS WITH RHEUMATOID ARTHRITIS
    Baser, O.
    Wang, L.
    Du, J.
    Wang, H.
    Xie, L.
    VALUE IN HEALTH, 2012, 15 (07) : A441 - A441
  • [29] Quality of care of rural, rheumatoid arthritis patients in Austria
    Puchner, R.
    Brezinschek, H.
    Herold, M.
    Nothnagl, T.
    Leeb, B.
    ZEITSCHRIFT FUR RHEUMATOLOGIE, 2013, 72 : 55 - 55
  • [30] Remission Rates of Patients with Rheumatoid Arthritis in a Tertiary Care
    Gildemeister, Nils
    Redeker, Imke
    Buehring, Bjoern
    Andreica, Ioana
    Kiefer, David
    Baraliakos, Xenofon
    Braun, Juergen
    Kiltz, Uta
    ARTHRITIS & RHEUMATOLOGY, 2021, 73 : 1621 - 1625